• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

着色芽生菌病。

Chromoblastomycosis.

机构信息

Mycology Section, Department of Dermatology, Dr. Manuel Gea Gonzalez General Hospital, Calzada de Tlalpan 4800, Colonia Sección XVI, Mexico, DF Mexico.

出版信息

Clin Dermatol. 2012 Jul-Aug;30(4):403-8. doi: 10.1016/j.clindermatol.2011.09.011.

DOI:10.1016/j.clindermatol.2011.09.011
PMID:22682188
Abstract

Chromoblastomycosis is a chronic, subcutaneous mycosis, characterized by verrucous nodular lesions, usually involving the legs and mainly caused by Fonsecaea, Phialophora, and Cladophialophora spp. The characteristic finding on direct examination or biopsy specimen is the presence of fumagoid cells or Medlar bodies. Chromoblastomycosis can be refractory to medical treatment. Therapeutic options include oral itraconazole, terbinafine, or 5-fluocytosine, alone or combined with surgery or cryosurgery.

摘要

着色芽生菌病是一种慢性皮下真菌病,特征为疣状结节病变,通常累及下肢,主要由帚霉属、瓶霉属和枝孢霉属引起。直接检查或活检标本的特征性发现是存在烟曲霉菌细胞或梅迪尔体。着色芽生菌病对药物治疗有抗性。治疗选择包括单独使用或与手术或冷冻手术联合使用口服伊曲康唑、特比萘芬或 5-氟胞嘧啶。

相似文献

1
Chromoblastomycosis.着色芽生菌病。
Clin Dermatol. 2012 Jul-Aug;30(4):403-8. doi: 10.1016/j.clindermatol.2011.09.011.
2
Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.由裴氏瓶霉引起的广泛性着色芽生菌病经两性霉素B和伊曲康唑联合治疗成功治愈。
Med Mycol. 2008 Mar;46(2):179-84. doi: 10.1080/13693780701721856.
3
[Chromomycosis: report of a case with unusual topography].[着色芽生菌病:1例罕见部位病例报告]
Rev Iberoam Micol. 2011 Jan-Mar;28(1):50-2. doi: 10.1016/j.riam.2010.11.006. Epub 2010 Dec 15.
4
Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.单孢瓶霉引起的着色芽生菌病的成功治疗:中国广东三例报告
Mycoses. 2009 Mar;52(2):176-81. doi: 10.1111/j.1439-0507.2008.01547.x. Epub 2008 Jun 21.
5
Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both.伊曲康唑、冷冻手术及两者联合治疗着色芽生菌病。
Int J Dermatol. 1997 Jul;36(7):542-7. doi: 10.1046/j.1365-4362.1997.00085.x.
6
Chromoblastomycosis associated with Fonsecaea pedrosoi in a carpenter handling exotic woods.一名接触外来木材的木匠患与裴氏瓶霉相关的着色芽生菌病。
Dermatol Online J. 2008 Feb 28;14(2):9.
7
Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.光动力疗法联合特比萘芬治疗着色芽生菌病及光动力疗法对单孢瓶霉的体外作用
Mycopathologia. 2015 Feb;179(1-2):103-9. doi: 10.1007/s11046-014-9828-3. Epub 2014 Nov 1.
8
Lymphangitic chromoblastomycosis.淋巴管型着色芽生菌病
Indian J Dermatol Venereol Leprol. 2006 Nov-Dec;72(6):443-5. doi: 10.4103/0378-6323.29342.
9
Images in clinical medicine. Chromoblastomycosis.临床医学影像。着色芽生菌病。
N Engl J Med. 2005 May 19;352(20):e19. doi: 10.1056/NEJMicm040848.
10
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.中国南方地区由 Fonsecaea 引起的着色芽生菌病:七例连续病例的临床病理、易感性和分子鉴定。
Clin Microbiol Infect. 2013 Nov;19(11):1023-8. doi: 10.1111/1469-0691.12067. Epub 2012 Nov 15.

引用本文的文献

1
Chromoblastomycosis in Peru: a retrospective review of 13 cases.秘鲁的着色芽生菌病:13例回顾性研究
BMC Infect Dis. 2025 Aug 28;25(1):1075. doi: 10.1186/s12879-025-11475-4.
2
The role of melanin in pathogenicity: adhesion, fibroblast interactions, and implications for chromoblastomycosis.黑色素在致病性中的作用:黏附、与成纤维细胞的相互作用以及对着色芽生菌病的影响。
Future Microbiol. 2025 Apr;20(6):449-456. doi: 10.1080/17460913.2025.2480973. Epub 2025 Mar 20.
3
An unusually subtle presentation of chromoblastomycosis.着色芽生菌病的一种异常隐匿的表现形式。
JAAD Case Rep. 2023 Aug 3;40:11-13. doi: 10.1016/j.jdcr.2023.07.029. eCollection 2023 Oct.
4
Chromoblastomycosis: A case series from Eastern China.着色芽生菌病:来自中国东部的一组病例。
PLoS Negl Trop Dis. 2022 Sep 26;16(9):e0010800. doi: 10.1371/journal.pntd.0010800. eCollection 2022 Sep.
5
Biofilm Formation by Chromoblastomycosis Fungi and : Involvement with Antifungal Resistance.着色芽生菌病真菌的生物膜形成及其与抗真菌耐药性的关系
J Fungi (Basel). 2022 Sep 15;8(9):963. doi: 10.3390/jof8090963.
6
Presence of hyphae in chromoblastomycosis examinations: an enigma to be solved.着色芽生菌病检查中菌丝的存在:一个有待解决的谜团。
An Bras Dermatol. 2021 Jul-Aug;96(4):490-493. doi: 10.1016/j.abd.2020.09.008. Epub 2021 May 15.
7
Unique Oral Presentations of Deep Fungal Infections: A Report of Four Cases.深部真菌感染的独特口腔表现:4 例报告。
Head Neck Pathol. 2021 Jun;15(2):682-690. doi: 10.1007/s12105-020-01217-0. Epub 2020 Sep 5.
8
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.对 MMV 病原体盒®的筛选揭示了针对着色芽生菌病病原体的新的潜在抗真菌药物。
PLoS One. 2020 May 13;15(5):e0229630. doi: 10.1371/journal.pone.0229630. eCollection 2020.
9
Aspartic peptidase of as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction.以天冬氨酰蛋白酶为靶点的 HIV 肽酶抑制剂:阻断其酶活性及干扰真菌生长和巨噬细胞相互作用。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):629-638. doi: 10.1080/14756366.2020.1724994.
10
Chromoblastomycosis caused by Rhinocladiella aquaspersa: first case report in Guatemala.水生枝孢霉引起的着色芽生菌病:危地马拉首例病例报告
An Bras Dermatol. 2019 Sep-Oct;94(5):574-577. doi: 10.1016/j.abd.2019.09.014. Epub 2019 Sep 30.